Vet Med - Czech, 2001, 46(9):257-274 | DOI: 10.17221/7883-VETMED
Quinolones: a class of antimicrobial agentsReview
- Department of Pharmacology and Toxicology, Faculty of Veterinary Science, Szent István University, Budapest, Hungary
The fluoroquinolones are a series of synthetic antibacterial agents that are used in the treatment of a variety of bacterial infections. These agents inhibit the DNA gyrase, abolishing its activity by interfering with the DNA-rejoining reaction. The inhibition of the resealing leads to the liberation of fragments that are subsequently destroyed by the bacterial exonucleases. All fluoroquinolones accumulate within bacteria very rapidly, so that a steady-state intrabacterial concentration is obtained within a few minutes. Resistance develops slowly and is usually chromosomal and not plasmid mediated. However, development of resistance and transfer between animal and human pathogens has become a fervently argued issue among the microbiologists. Another concern regarding the use of new quinolones in the veterinary field is a possible detrimental effect on the environment. It still seems unlikely that the controlled use of veterinary quinolones will give rise to unfavorable effects on the environment.
Keywords: fluoroquinolones; chemistry; pharmacokinetics; resistance; therapeutical use
Published: September 30, 2001 Show citation
References
- Abadía A.R., Aramayona J.J., Fraile L., Martinez C., Garcia M.A., Bregante M.A. (1994a): Pharmacokinetics of enrofloxacin and ciprofloxacin during ontogeny in the rabbit. In: Proceedings of the Sixth Congress of the European Association for Veterinary Pharmacology and Toxicology. Edinburgh, Scotland. 231.
- Abadía A.R., Aramayona J.J., Muñoz M.J., Pla Delfina J.M., Saez M.P., Bregante M.A. (1994b): Disposition of ciprofloxacin following intravenous administration in dogs. J. Vet. Pharmacol. Therap., 17, 384-388. Go to original source... Go to PubMed...
- Akahane K., Segiguchi M., Une T., Osoda Y. (1989): Structure-epileptogenicity relationship of quinolones with special reference their interaction with γ-amino-butiric acid receptor sites. Antimicrob. Agents Chemother., 33, 1704-1708. Go to original source... Go to PubMed...
- Althreuther P. (1987): Data on chemistry and toxicology of Baytril. Vet. Med. Rev., 2, 87-89.
- Anadón A., Martínez-Larrañaga M.R., Díaz M.J., Fernández R., Martínez M.A., Fernández-Cruz M.L., Fernández M.C. (1994): Pharmacokinetic properties of norfloxacin in pigs. In: Proceedings of the Sixth Congress of the European Associassion for Veterinary Pharmacology and Toxicology. Edinburgh, Scotland. 230-231.
- Anadón A., Martínez-Larrañaga M.R., Díaz M.J., Bringas P., Martínez M.A., Fernández-Cruz M.L., Fernández M.C., Fernández R. (1995): Pharmacokinetics and residues of enrofloxacin in chickens. Am. J. Vet. Res., 56, 501-506.
- Apley M.D., Upson D.W. (1993a): Regional danafloxacin lung tissue concentrationsand their relationship to regional pulmonary blood flow in consolidated and nonconsolidated bovine lung. Am. J. Vet. Res., 54, 944-951.
- Apley M.D., Upson D.W. (1993b): Lung tissue concentrations and plasma pharmacokinetics of danofloxacin in calves with acute pneumonia. Am. J. Vet. Res., 54, 937-943.
- Aramayona J.J., Garcia M.A., Fraile L.J., Abadfa A.R., Bregante M.A. (1994): Placental transfer of enrofloxacin and ciprofloxacin in rabbits. Am. J. Vet. Res., 55, 1313- 1318.
- Ashby J., Piddock L.J.V., Vise R. (1985): Correspondence: An investigation of the hydrophobicity of the quinolones. J. Antimicrob. Chemother., 16, 805-808. Go to original source... Go to PubMed...
- Ball P. (1986): Ciprofloxacin: an overview of adverse experiments. J. Antimicrob.Chemother., 18 (suppl. D), 187-193. Go to original source... Go to PubMed...
- Barza M. (1991): Use of quinolones for treatment of ear and eye infections. Eur. J. Clin. Microbiol. Infect. Dis., 10, 296-303. Go to original source... Go to PubMed...
- Bates S.A., Elder M.G. (1988): An evaluation of pelvic tissue concentrations after oral administration of enoxacin. J. Antimicrob. Chemother., 21 (Suppl. B), 79-85. Go to original source... Go to PubMed...
- Bayer A.S., Hirano L., Yih J. (1988): Development of β-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis. Antimicrob. Agents Chemother., 32, 231-235. Go to original source... Go to PubMed...
- Beam T.R. jr. (1994): Fluoroquinolones in Animal Feeds. Am. Soc. Microbiol. News, 60, 348-349.
- Berg J. (1988): Clinical indications for enrofloxacin in domestic animals and poultry. In: Quinolones: A new class of antimicrobial agents for use in veterinary medicine. In: Proc. West Vet. Conf, Las Vegas, Nevada: Mobay Corporation.
- Bhaumik A. (1997): Effect of norfloxacin treatment in acute enteritis in dogs. Indian Vet. J., 74, 246-247.
- Blaser J., Stone B.B., Groner M.C., Zinner S.H. (1987): Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob. Agents Chemother., 31, 1054-1060. Go to original source... Go to PubMed...
- Blaser J., Lüthy R. (1988): Comparative study on antagonistic effects of low pH and cation supplementation on in-vitro activity of quinolones and aminoglycosides against Pseudomonas aeruginosa. J. Antimicrob. Chemother., 22, 15-22. Go to original source... Go to PubMed...
- Bowles S.K., Popovski Z., Rybak M.J., Beckman H.B., Edwards D.J. (1988): Effects of norfloxacin on theophylline pharmacokinetics in steady-state. Antimicrob. Agents Chemother., 32, 510-513. Go to original source... Go to PubMed...
- Braunius W.W. (1987): Effect van Baytril™ (Bay Vp 2674) op jonge kalkoenen lijdende aan luchtweginfecties. Tijdschr. Diergeneeskd, 112, 531-533. Go to PubMed...
- Bregante M.A., Abadía A.R., Mora J., Aramayona J.J., Garcia M.A., Fraile L. (1994): Milk transfer of enrofloxacin and ciprofloxacin in the rabbit. In: Proceedings of the Sixth Congress of the European Associassion for Veterinary Pharmacology and Toxicology. Edinburgh, Scotland. 231-232.
- Brown S.A., Cooper J., Gauze J.J., Greco D.S., Weise D.W., Buck J.M. (1990): Pharmacokinetics of norfloxacin in dogs after a single intravenous and single and multiple oral administrations of the drug. Am. J. Vet. Res., 51, 1065-1070.
- Brumfitt W., Franklin I., Grady D., Hamilton-Miller J.M.T., Iliffe A. (1984): Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob. Agents Chemother., 26, 757-761. Go to original source... Go to PubMed...
- Carlier M.B., Scorneaux B., Zenebergh A., Desnottes J.F., Tulkens P.M. (1990): Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages. J. Antimicrob. Chemother., 26 (Suppl. B), 27-39. Go to original source... Go to PubMed...
- Chamberland S., Bayer A.S., Schollaardt T., Wong S.A., Bryan L.E. (1989): Characterization of mechanism of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis. Antimicrob. Agents Chemother., 33, 624-634. Go to original source... Go to PubMed...
- Chang T., Black A., Dunkey A., Wolf R., Sedman A., Latts J., Welling P.G. (1988): Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers. J. Antimicrob. Chemother., 21 (Suppl. B.), 49-56. Go to original source... Go to PubMed...
- Chapman J.S., Georgopapadakou N.H. (1988): Routes of quinolone permeation in E. coli. Antimicrob. Agents Chemother., 32, 438-442. Go to original source... Go to PubMed...
- Chen Z., Fung K.F., Fang B., Song Y. (1994): Antimicrobial and pharmacokinetic studies of fluoroquinolones in chickens. In: Proceedings of the Sixth Congress of the European Associassion for Veterinary Pharmacology and Toxicology. Edinburgh, Scotland. 209-210.
- Chu D., Fernandez P., Claiborne A., Shen L., Pernet A. (1988): Structure-activity relationships in quinolone antimicrobials: design, synthesis and biological activities of novel isothiazoquinolones. Drugs Exp. Clin. Res., 14, 379-383.
- Cooper A.D., Fuller J.R., Fuller M.K., Whitlestone P., Wise, D.R. (1993): In vitro activity of danofloxacin, tylosin and oxytetracycline against mycoplasmas of veterinary importance. Res. Vet. Sci., 54, 329-334. Go to original source... Go to PubMed...
- Cutarelli P.E., Laso J.H., Lazarus H.M., Putnam S.P., Jacobs M.R. (1991): Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity. Curr. Eye Res., 10, 557-563. Go to original source... Go to PubMed...
- Dalhoff A., Weidner W. (1984): Diffusion of ciprofloxacin into prostatic fluid. Eur. J. Clin. Microbiol., 3, 360-362. Go to original source... Go to PubMed...
- Darouiche R., Perkins B., Musher D., Hamill R., Tsai S. (1990): Levels of rifampin and ciprofloxacin in nasal secretions: correlation with MIC90 and eradication of nasopharyngeal carriage of bacteria. J. Inf. Dis., 162, 1124-1127. Go to original source... Go to PubMed...
- Desgrandchamps D. (1989): Increasing rates of in vitro resistance to ciprofloxacin and norfloxacin in isolates from urine specimens. Antimicrob. Agents Chemother., 33, 595-596. Go to original source... Go to PubMed...
- Desnottes J.F., Diallo N., Moret G., Santonja R. (1987): Effects of subinhibitory concentrations of pefloxacin on the adherence of Staphylococcus aureus to human cells. Drugs Exp. Clin. Res., 13, 69-73.
- Dijkstra J.W., McConville M.L., Nouws J.F.M. (1994): Effects of srafloxacin hydrochloride on human enteric bacteria under simulated human gut conditions. In: Proceedings of the Sixth Congress of the European Association for Veterinary Pharmacology and Toxicology, Edinburgh, Scotland. 75.
- Diver J.M., Wise R. (1986): Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin. J. Antimicrob. Chemother., 18 (suppl. D), 31-41. Go to original source... Go to PubMed...
- Dobbs B.R., Gazeley L.R., Stewart I.A., Edwards I.R. (1988): Pharmacokinetics and sputum concentrations of enoxacin after twice daily oral dosing for seven days. J. Antimicrob. Chemother., 21 (Suppl. B), 61-66. Go to original source... Go to PubMed...
- Dorfman M., Barsanti J., Budsberg S. (1995): Enrofloxacin concentrations in dogs with the normal prostate and dogs with chronic bacterial prostatitis. Am. J. Vet. Res., 56, 386-390.
- Dowling P.M., Wilson R.C., Tyler J.W., Duran S.H. (1995): Pharmacokinetics of ciprofloxacin in ponies. J. Vet. Pharmacol. Therap., 18, 7-12. Go to original source... Go to PubMed...
- Drusano G.L., Plaisance K.I., Forrest A., Standiford H.C. (1986): Dose ranging study and constant infusion evaluation of ciprofloxacin. Antimicrob. Agents Chemother., 30, 440-443. Go to original source... Go to PubMed...
- Drusano G.L., Johnson D.E., Rosen M., Standiford H. C. (1993): Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas spesis. Antimicrob. Agents Chemother., 37, 483-490. Go to original source... Go to PubMed...
- Duval J.M., Budsberg S.C. (1995): Cortical bone concentrations of enrofloxacin in dogs. Am. J. Vet. Res., 56, 188-192.
- Endtz H.P., Rujis G.J., Van Klingeren B., Jansen W.H., Van der Reyden T., Mouton R. P. (1991): Quinolone resistance in campylobacter isolated from manand poultry following the introduction of fluoroquinolones in veterinary medicine. J. Antimicrob. Chemother., 27, 199-208. Go to original source... Go to PubMed...
- Felmingham D., Foxal P., O'Hare M.D., Webb G., Ghosh G., Grüneberg R.N. (1988): Resistance studies with ofloxacin. J. Antimicrob. Chemother., 22 (Suppl. C), 27-34. Go to original source... Go to PubMed...
- Fernandes P.B. (1988): Mode of action, and in vitro and in vivo activities of the fluoroquinolones. J. Clin. Pharmacol., 28, 156-168. Go to original source... Go to PubMed...
- Fitzgeorge R., Featherstone A., Baskerville A. (1988): The effect of ofloxacin on the intracellular growth of Legionella pneumophila in guinea pig alveolar phagocytes. J. Antimicrob. Agents Chemother., 22 (Suppl. S), 53-57. Go to original source... Go to PubMed...
- Foerster D. (1987): Visualization of the bactericidal action of Baytril by microphotography. Vet. Med. Rev., 2, 100-103.
- Forrest A., Nix D.E., Ballow C.H., Goss T.F., Birmingham M.C., Schentag J.J. (1993): Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob. Agents Chemother., 37, 1073-1081. Go to original source... Go to PubMed...
- Friis C. (1991): Danofloxacin in calves: pharmacokinetics and penetration into the respiratory tract tissue, Acta Vet. Scand., (Suppl.), 87, 104-106.
- Friis C. (1994): Penetration of danofloxacin into respiratory tract tissues and secretions in pigs. In: Proceedings of the Sixth Congress of the European Associassion for Veterinary Pharmacology and Toxicology. Edinburgh, Scotland. 208-209.
- Frost R.W., Carlson J.D., Dietz A.J.,Jr., Heyd A., Lettieri J.T. (1989a): Ciprofloxacin pharmacokinetics after a standard or high-fat/high-calcium breakfast. J. Clin. Pharmacol., 29, 953-955. Go to original source... Go to PubMed...
- Frost R.W., Lettieri J.T., Krol G., Shamblen E.C., Lasseter K.C. (1989b): The effects of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin. Clin. Pharmacol. Therap., 45, 608-616. Go to original source... Go to PubMed...
- Furet Y.X., Pechére J.C. (1991): Newly documented antimicrobial activity of quinolones. Eur. J. Clin. Microbiol. Infect. Dis., 10, 249-254. Go to original source... Go to PubMed...
- Gasser T., Graversen P., Madsen P. (1987): Treatment of complicated urinary tract infections with ciprofloxacin. Am. J. Med., 82 (Suppl. 4A), 278-281.
- Giamarellou H., Kolokythas E., Petrikkos G., Gazis J., Aravantino D., Sfikakis P. (1989): Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am. J. Med., 87 (Suppl. 5A), 49-51. Go to original source... Go to PubMed...
- Giles C.J., Magonigle R.A., Grimshaw W.T.R., Tanner A.C., Risk J.E., Lynch M.J., Rice J.R. (1991): Clinical pharmacokinetics of parenterally administered danofloxacin in cattle. J. Vet. Pharmacol. Therap., 14, 400-410. Go to original source... Go to PubMed...
- Giles C.J., Grimshaw W.T.R., Shanks D.J. et al. (1991): The efficacy of danofloxacin in the therapy of acute bacterial pneumonia in housed beef cattle. Vet. Rec., 128, 296-300. Go to original source... Go to PubMed...
- Goodman L.S., Gilman A. (1992): The Pharmacological Basis of Therapeutics. 8th ed. New York, Macmillan. 1057.
- Gootz T.D., McGuirk P.R., Moynihon M.S., Haskell S.L. (1994): Placement of alkyl substituents on the C7 piperazine ring of fluoroquinolones: Dramatic differential effects on mammalian topoisomerase II and DNA gyrase. Antimicrob. Agents Chemother., 38, 130-133. Go to original source... Go to PubMed...
- Gould I.M., Milne K., Jason C. (1990): Concentration-dependent bacterial killing, adaptive resistance and post-antibiotic effect of ciprofloxacin alone and in combination with gentamycin. Drugs Exp. Clin. Res., 26, 621-628.
- Grasela T.J.Jr., Schentag J.J., Sedman A.J., Wilton J.H., Thomas D.J., Schultz R.W., Lebsack M.E., Kinkel A.W. (1989): Inhibition of enoxacin absorption by antacids or ranitidine. Antimicrob. Agents Chemother., 33, 615-617. Go to original source... Go to PubMed...
- Greenwood D., Baxter S., Cowlishaw A., Eley A., Slater G.J. (1984): Antibacterial activity of ciprofloxacin in conventional tests and in a model of bacterial cystitis. Eur. J. Clin. Microbiol., 3, 351-354. Go to original source... Go to PubMed...
- Grimshaw W.T.R., Magonigle R.A., Giles C.J., Tanner A.C., Risk J.E., Lynch M.J., Rice J.R. (1990a): The pharmacokinetics of danofloxacin in cattle. In: XVI World Buiatrics Congress, Salvador, Bahia, Brazil.
- Grimshaw W.T.R., Giles C.J., Cooper A.C. et al. (1990b): The efficacy of danofloxacin in the therapy of pneumonia associated with Pasteurella species in housed calves. Dtsch. Tierarztl. Wschr., 97, 529-532.
- Gulkarov A., Ziv G. (1994): Some pharmacokinetic features of norfloxacin nicotinate in turkeys. In: Proceedings of the Sixth Congress of the European Association for Veterinary Pharmacology and Toxicology. Edinburgh, Scotland. 235.
- Gyrd-Hansen N., Nielsen P. (1994): The influence of feed on the oral bioavailability of enrofloxacin, oxytetracycline, penicillin V and spiramycin in pigs. In: Proceedings of the Sixth Congress of the European Associassion for Veterinary Pharmacology and Toxicology. Edinburgh, Scotland. 242-243.
- Harder S., Staib A.H., Beer C., Papenburg A., Stille W., Shah P.M. (1988): 4-Quinolones inhibit biotransformation of caffeine. Eur. J. Clin. Pharmacol., 35, 651-656. Go to original source... Go to PubMed...
- Hayem G., Petit P.X., LeVacher M., Gaudin C., Kahr M.F., Pocidalo J.J. (1994): Cytofluorometric analysis of chondrotoxicity of fluoroquinolone antimicrobial agents. Antimicrob. Agents Chemother., 38, 243-247. Go to original source... Go to PubMed...
- Hinz K.H., Rottmann S. (1990): Studies in vivo on the efficacy of enrofloxacin against Mycoplasma gallisepticum. Avian Pathol., 19, 511-522. Go to original source... Go to PubMed...
- Höffler D., Dalhoff A., Gau W., Beerman D., Michael A. (1984): Dose- and sex independent disposition of ciprofloxacin. Eur. J. Clin. Microbiol., 3, 363-366. Go to original source... Go to PubMed...
- Hoogkamp-Korstanje J.A.A. (1984): Comparative in vitro activity of five quinolone derivates and five other antimicrobial agents used in oral therapy. Eur. J. Clin. Microbiol., 3, 333-338. Go to original source... Go to PubMed...
- Hooper D., Wolfson J. (1985): The fluoroquinolones: Structures, mechanisms of action and resistance and spectra of activity in vitro. Antimicrob. Agents Chemother., 28, 581- 586. Go to original source... Go to PubMed...
- Hooper D.C., Wolfson J.S. (1991): Mode of action of the new quinolones: new data. Eur. J. Clin. Microbiol. Inf. Dis., 10, 223-231. Go to original source... Go to PubMed...
- Jackson J.A., Davidson J.N., Ter Hune T.N., Magonigle R.A. (1990): A dose response study of the fluoroquinolone, danofloxacin, against induced bovine pneumonic pasteurellosis. In: XVI World Buiatrics Congress, Salvador, Bahia, Brazil.
- Janin N., Meugnier H., Desnottes J.F., Woehrle R., Fleurette J. (1987): Recovery of pefloxacin in saliva and feces and its action on oral and fecal floras of healthy volunteers. Antimicrob. Agents Chemother., 31, 1665-1668. Go to original source... Go to PubMed...
- Jenkins W., Friedlander L. (1988): The pharmacology of the quinolone antibacterial agents. In: Quinolones: A new class of antimicrobial agents for use in veterinary medicine. Proc. West Vet. Conf, Las Vegas, Nevada: Mobay Corporation Animals Health Division, Shawnee, Kansas. 5-16.
- Jordan F.T.W., Horrocks B.K., Jones S.K., Cooper A.C., Giles C.J. (1993): A comparison of the efficacy of danofloxacin and tylosin in the control of Mycoplasma gallisepticum infection in broiler chicks. J. Vet. Pharmacol. Toxicol., 16, 79-86. Go to original source... Go to PubMed...
- Kaatz G.W., Seo S.M., Ruble C.A. (1991): Mechanisms of fluoroquinolone resistance of Staphylococcus aureus. J. Infect. Dis., 163, 1080-1086. Go to original source... Go to PubMed...
- Kato M., Onedara T. (1988): Effect of ofloxacin on the uptake of (3H) thymidine by articular cartilage cells in rat. Toxicol. Lett., 44, 131-142. Go to original source... Go to PubMed...
- Kempf I., Gesbert F., Guittet M., Bennejean G. (1992): Efficacy of danofloxacin in the therapy of experimental mycoplasmosis in chicks. Res.. Vet. Sci., 53, 257-259. Go to original source... Go to PubMed...
- Kotera Y., Watanabe M., Yoshida S., Inoue M., Mitsuhashi S. (1991): Factors influencing the uptake of norfloxacin by Escherichia coli. J. Antimicrob. Chemother., 27, 733-739. Go to original source... Go to PubMed...
- Kresken M., Wiedemann B. (1988): Development of resistance to nalidic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Antimicrob. Agents Chemother., 32, 1285-1288. Go to original source... Go to PubMed...
- Küng K., Riond J.L., Wolffram S., Wanner M. (1993): Comparison of an HPLC and bioassay method to determine antimicrobial concentrations after intravenous and oral administration of enrofloxacin in four dogs. Res. Vet. Sci., 54, 247-248. Go to original source... Go to PubMed...
- Lavy E., Ziv G., Glickman A. (1994): Pharmacokinetics of norfloxacin in the donkey (Equus asinus). In: Proceedings of the Sixth Congress of the European Association for Veterinary Pharmacology and Toxicology. Edinburgh, Scotland. 52-53.
- Lekeux P., Art T. (1988): Effect of enrofloxacin therapy on shipping fever pneumonia in feedlot cattle. Vet. Rec., 123, 205-207. Go to original source... Go to PubMed...
- Lode H., Höffken G., Prinzig C., Glatzel P., Wiley R., Olschewski P., Sievers B., Reimnitz D., Borner K., Koeppe P. (1987): Comparative pharmacokinetics of new quinolones. Drugs, 34 (Suppl. 1), 21-25. Go to original source... Go to PubMed...
- Lode H., Höffken G., Boeckk M., Deppermann N., Borner K., Koeppe P. (1990): Quinolone pharmacokinetics and metabolism. J. Antimicrob. Chemother., 26 (Suppl. B4), 1-9. Go to original source... Go to PubMed...
- Ludwig E., Székely É., Csiba A., Graber H. (1988): The effect of ciprofloxacin on antipyrine metabolism. J. Antimicrob. Chemother., 22, 61-67. Go to original source... Go to PubMed...
- Maesen F.P.V., Davies B.I., Geraeds W.H., Baur C. (1987): The use of quinolones in respiratory tract infections. Drugs, 34 (Suppl 1), 74-79. Go to original source... Go to PubMed...
- Malmborg A.S., Rannikko S. (1988): Enoxacin distribution in human tissues after multiple oral administration. J. Antimicrob. Chemother., 21 (Suppl. B), 57-60. Go to original source... Go to PubMed...
- Martínez-Larrañaga M.R., Díaz M.J., Bringas P., Fernández M.D., Fernández-Cruz M.L., Martínez M.A., Anadón A. (1994): Bioavalability and residues of enrofloxacin and its metabolite ciprofloxacin in broiler chickens. In: Proceedings of the Sixth Congress of the European Association for Veterinary Pharmacology and Toxicology. Edinburgh, Scotland. 238-239.
- McQueen C., Williams G. (1987): Effects of quinolone antibiotics in tests for genotoxicity. Am. J. Med., 82 (Suppl. 4A), 94-96.
- Mevius D.J., Breukink H.J., Guelen P.J.M., Jansen T., De Gréve B. (1990): Pharmacokinetics, metabolism and renal clearance of flumequine in veal calves. J. Vet. Pharmacol. Therap., 13, 159-169. Go to original source... Go to PubMed...
- Montay G., Goueffon Y., Roquet F. (1984): Absorption, distribution, metabolic fate and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys and humans. Antimicrob. Agents Chemother., 25, 463-472. Go to original source... Go to PubMed...
- Neer T.M. (1988): Clinical pharmacologic features of fluoroquinolone antimicrobial drugs. J. Am. Vet. Med. Assoc., 193, 577-580. Go to PubMed...
- Neu H.C. (1988): Quinolones: A new class of antimicrobial agents with wide potential uses. Med. Clin. North Am., 72, 623-636. Go to original source... Go to PubMed...
- Neu H.C. (1991): Synergy and antagonism of combinations with quinolones. Eur. J. Clin. Microbiol. Infect. Dis., 10, 255-261. Go to original source... Go to PubMed...
- Neu H.C., Kumada T., Chin N.X., Mandell W. (1987): The post-antimicrobial suppressive effect of quinolone agents. Drugs Exp. Clin. Res., 13, 63-67.
- Nikaido H., Thanassi D.G. (1993): Minireview: Penetration of lipophilic agents with multiple protonation sites into bacterial cells: Tetracyclines and fluoroquinolones as examples. Antimicrob. Agents Chemother., 37, 1393-1399. Go to original source... Go to PubMed...
- Nix D.E., Schentag J.J. (1988): The quinolones: an overview and comparative appraisal of their pharmacokinetics and pharmacodynamics. J. Clin. Pharmacol., 28, 169- 178. Go to original source... Go to PubMed...
- Nix D.E., Watson W.A., Lener M.E., Frost R..W., Krol G., Goldstein H., Lettieri J., Schentag J.J. (1989): Effects of aluminium and magnesium antacids and ranitidine on the absorption of ciprofloxacin. Clin. Pharmacol. Therap., 46, 700-705. Go to original source... Go to PubMed...
- Norrby S.R. (1991): Side effects of quinolones: Comparisons between quinolones and other antibiotics. Eur. J. Clin. Microbiol. Infect. Dis., 10, 378-383. Go to original source... Go to PubMed...
- Novotny M.J., Shaw D.H. (1991): Effect of enrofloxacin on digoxin clearance and steady-state serum concentrations in dogs. Can. J. Vet. Res., 55, 113-116.
- Okazaki O., Kurata T., Tachizawa H. (1988): Effect of new quinolones on drugmetabolizing enzyme system of rat hepatic microsomes. Chemotherapy, 34, 149-154. Go to original source... Go to PubMed...
- Oomori Y., Yasue T., Aoyma H., Hirai K., Suzue S., Yokota T. (1988): Effects of fleroxacin on HeLa cell functions and topoisomerase II. J. Antimicrob. Chemother., 22 (Suppl. D), 91-97. Go to original source... Go to PubMed...
- Parpia S., Nix D., Hejmanowski H., Wilton J., Schentag J. (1989): Sucralfate reduces the gastrointetinal absorption of norfloxacin. Antimicrob. Agents Chemother., 33, 99- 102. Go to original source... Go to PubMed...
- Patil V.K., Keskar D.V., Jagadish S., Bhalerao D.P., Sharma L.K. (1995): Clinicopathology of urinary tract infections in dogs. Indian Vet. J., 72, 374-377.
- Pérez-Trallero E., Urbieta M., Jimenez D., Garcia-Arenzana J.M., Cilla G. (1993): Ten-year survey of quinolone resistance in Escherichia coli causing urinary tract infections. Eur. J. Clin. Microbiol. Infect. Dis., 12, 349-351. Go to original source... Go to PubMed...
- Piddock L.J. (1994): New quinolones and Gram-positive bacteria. Antimicrob. Agents Chemother., 38, 163-169. Go to original source... Go to PubMed...
- Piddock L.J.V., Wise R. (1989): Mechanism of resistance to quinolones and clinical perspectives. J. Antimicrob. Chemo-ther., 23, 475-483. Go to original source... Go to PubMed...
- Pijpers A., Vernooy J.C.M., Cruijsen A.L.M., Van Leengoed L.A.M.G., Koeman J., Hessels A.H., Vandenhoek J., Verheijden J.H.M. (1994): Efficacy of parenteral treatment with oxytetracycline and enrofloxacin against Actinobacillus pleuropneumoniae in swine. In: Proceedings of the Sixth Congress of the European Association for Veterinary Pharmacology and Toxicology. Edinburgh, Scotland. 93.
- Preheim L., Cuevas T., Roccaforte J., Mellencamp M., Bittner M. (1987): Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria. Am. J. Med., 82 (Suppl. 4A), 295-297.
- Prescott J.F., Yielding K.M. (1990): In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Can. J. Vet. Res., 54, 195-197.
- Pyörälä S., Panu S., Kaartinen L. (1994): Single-dose pharmacokinetics of enrofloxacin in horses. In: Proceedings of the Sixth Congress of the European Association for Veterinary Pharmacology and Toxicology, Edinburgh, Scotland. 45-46.
- Ramon J., Dautrey S., Farinoti R., Carbón C., Rubenstein E. (1994): Intestinal elimination of ciprofloxacin in rabbits. Antimicrob. Agents Chemother., 38, 757-760. Go to original source... Go to PubMed...
- Richez P., Dellac B., Froyman R. (1994): Pharmacokinetics of enrofloxacin in pigs after single and repeated in-feed medication with Baytril 2.5%. In: Proceedings of the Sixth Congress of the European Association for Veterinary Pharmacology and Toxicology. Edinburgh, Scotland. 207-208.
- Ridgway G.L., Mumtaz G., Gabriel F.G., Oriel J.D. (1984): The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro. Eur. J. Clin. Microbiol., 3, 344-346. Go to original source... Go to PubMed...
- Rowan R.C., Mullenix T.A., Arroyo J.C., Voris J.C. (1988): Development of Pseudomonas aeruginosa resistance to norfloxacin during therapy. Drug Intellig. Clin. Pharm., 22, 773-776. Go to original source... Go to PubMed...
- Rybak M.J., Bowles S.K., Chandrasekar P.H., Edwards D.J. (1987): Increased theophylline concentration secondary to ciprofloxacin. Drug Intellig. Clin. Pharm., 21, 879-881. Go to original source... Go to PubMed...
- Semjén G., Blaskó É. (1994): In vitro emergence of resistance of flumequine and enrofloxacin in strains of Staphylococcus aureus. In: Proceedings of the Sixth Congress of the European Association for Veterinary Pharmacology and Toxicology, Edinburgh, Scotland. 239-240.
- Sheer M. (1987): Concentrations of active ingredient in the serum and in tissues after oral and parenteral administration of Baytril. Vet. Med. Rev., 2, 104-118.
- Smith J.T. (1984): Mutational resistance to 4-quinolone antibacterial agents. Eur. J. Clin. Microbiol., 3, 347-350. Go to original source... Go to PubMed...
- Smith J.T. (1986): The mode of action of 4-quinolones and possible mechanisms of resistance. J. Antimicrob. Chemo-ther., 18 (suppl. D), 21-29. Go to original source... Go to PubMed...
- Soback S., Gips M., Bialer M. (1994a): Norfloxacin nicotinate pharmacokinetics in unweaned and weaned calves. In: Proceedings of the Sixth Congress of the European Association for Veterinary Pharmacology and Toxicology, Edinburgh, Scotland. 63-64.
- Soback S., Gips M., Bialer M., Bor A. (1994b): Effect of lactation on single-dose pharmacokinetics of norfloxacin nicotinate in ewes. Antimicrob. Agents Chemother., 38, 2336-2339. Go to original source... Go to PubMed...
- Sorgel F., Seelman R., Naber K., Metz R., Muth P. (1988): Metabolism of fleroxacin in man. J. Antimicrob. Agents Chemother., 22 (Suppl. D), 169-178. Go to original source... Go to PubMed...
- Sorgel F., Jaehde U., Naber K., Stephan U. (1989): Pharmacokinetic disposition of fluoroquinolones in human body fluids and tissues. Clin. Pharmacokin., 16 (Suppl. 1), 5- 24. Go to original source... Go to PubMed...
- Studdert V.P., Hughes K.L. (1992): Treatment of opportunistic mycobacterial infections with enrofloxacin in cats. J. Am. Vet. Med. Assoc., 201, 1388-1390. Go to PubMed...
- Sullivan M.C., Cooper B.W., Nightingale C.H., Quintiliani R., Lawlor M.T. (1993): Evaluation of the efficacy of cipro-floxacin against Streptococcus pneumoniae by using a mouse protection model. Antimicrob. Agents Chemother., 37, 234-239. Go to original source... Go to PubMed...
- Swanson R.N., Hardy D.J., Chu D.T.W., Shipkowitz N.L., Clement J.J. (1991): Activity of temafloxacin against respiratory pathogens. Antimicrob. Agents Chemother., 35, 423-429. Go to original source... Go to PubMed...
- Takács-Novák K., Noszal B., Hermecz I., Keresztúri G., Podányi B., Szász G. (1990): Protonation equilibria of quinolone antibacterials. J. Pharm. Sci., 79, 1023-1028. Go to original source... Go to PubMed...
- Takayama S., Watanabe T., Akiyama Y. et al. (1986): Reproductive toxicity of ofloxacin. Arzneimittelforschung, 36, 1244-1248. Go to PubMed...
- Thomas V., Deleforge J., Bolsramé B. (1994a): Pharmacokinetics of marbofloxacin in preruminant and ruminant cattle. In: Proceedings of the Sixth Congress of the European Association for Veterinary Pharmacology and Toxicology, Edinburgh, Scotland. 60-61.
- Thomas V., Deleforge J., Bolsramé B., Espinasse J. (1994b): Pharmacokinetics of marboflaxicin in healthy and sick pre-ruminant calves. In: Proceedings of the Sixth Congress of the European Association for Veterinary Pharmacology and Toxicology, Edinburgh, Scotland. 61.
- Thoung-Guyot M., Domarle O., Pacidalo J.J., Hayem G. (1994): Effects of fluoroquinolones on cultured articular chondrocytes flow cytometric analysis of free radical production. J. Pharmacol. Exp. Therap., 271, 1544-1549.
- VanCutsem P.M., Babish J.G., Schwark W.S. (1990): The fluoroquinolone antimicrobials: Structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Vet., 80, 173-186. Go to PubMed...
- Venezia R.A., Prymas L.A., Shayegani A., Yocum D.M. (1989): In vitro activities of amifloxacin and two of its metabolites. Antimicrob. Agents. Chemother., 33, 762-766. Go to original source... Go to PubMed...
- Voight W.H. (1987): Electron microscopic studies on the effect of a quinolone carboxylic acid derivative on the ultrastructure of Escherichia coli and staphylococcal bacteria in vitro. Vet. Med. Rev., 2, 119-121.
- Walker R.D., Stein G.E., Budsberg S.C., Rosser E.J.Jr., MacDonald K.H. (1989): Serum and tissue fluid norfloxacin concentrations after oral administration of the drug to healthy dogs. Am. J. Vet. Res., 50, 154-157.
- Walker R.D., Stein G.E., Hauptman J.G., MacDonald K.H., Budsberg S.C., Rosser E.J.Jr. (1990): Serum and tissue cage fluid concentrations of ciprofloxacin after oral administration of the drug to healthy dogs. Am. J. Vet. Res., 51, 896-900.
- Walker R.D., Stein G.E., Hauptman J.G., McDonald K.H. (1992): Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs. Am. J. Vet. Res., 53, 2315-2319.
- Watanabe M., Kotera Y., Yosue K., Inoue M., Mitsuhashi S. (1990): In vitro emergence of quinolone-resistant mutants of E. coli, Enterobacter cloaceae and Serratia marcescens. Antimicrob. Agents. Chemother., 34, 173-175. Go to original source... Go to PubMed...
- Wolfson J.S., Hooper D.C. (1991): Pharmacokinetics of quinolones: newer aspects. Eur. J. Clin. Microbiol. Infect. Dis., 10, 267-274. Go to original source... Go to PubMed...
- Yamamoto T., Watanabe K., Horikita T. et al. (1992): Therapeutic efficacy of enrofloxacin to swine Actinobacillus pleuropneumoniae infection. Kachiku Shinryo, 352, 19- 27.
- Zweerink M.M., Edison A.M. (1988): The uptake of 3H-norfloxacin by human polymorphonuclear leukocytes. J. Antimicrob. Chemother., 21, 266-267. Go to original source... Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.